1350 Solid tumour-induced systemic immunosuppression involves dichotomous myeloid–B cell interactions
https://www.nature.com/articles/s41556-024-01508-6
1349 Probiotic neoantigen delivery vectors for precision cancer immunotherapy
https://www.nature.com/articles/s41586-024-08033-4
1348 Colibactin-driven colon cancer requires adhesin-mediated epithelial binding
https://www.nature.com/articles/s41586-024-08135-z
1347 Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity
https://www.cell.com/cell/abstract/S0092-8674(24)00898-5
1346 Tumour evolution and microenvironment interactions in 2D and 3D space
https://www.nature.com/articles/s41586-024-08087-4
1345 Temporal recording of mammalian development and precancer
https://www.nature.com/articles/s41586-024-07954-4
1344 The periosteum provides a stromal defence against cancer invasion into the bone
https://www.nature.com/articles/s41586-024-07822-1
1343 Glycosphingolipid synthesis mediates immune evasion in KRAS-driven cancer
https://www.nature.com/articles/s41586-024-07787-1
1342 Inhibition of colorectal cancer in Alzheimer’s disease is mediated by gut microbiota via induction of inflammatory tolerance
https://www.pnas.org/doi/10.1073/pnas.2314337121
1341 Targeting cancer with small-molecule pan-KRAS degraders
https://www.science.org/doi/10.1126/science.adm8684
1340 RAD21 promotes oncogenesis and lethal progression of prostate cancer
https://www.pnas.org/doi/10.1073/pnas.2405543121
1339 Tumour vasculature at single-cell resolution
https://www.nature.com/articles/s41586-024-07698-1
1338 Proteobacteria impair anti-tumor immunity in the omentum by consuming arginine
https://www.cell.com/cell-host-microbe/abstract/S1931-3128(24)00197-5
1337 Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer
https://www.science.org/doi/10.1126/science.adh4567
1336 A TME-enlightened protein-binding photodynamic nanoinhibitor for highly effective oncology treatment
https://www.pnas.org/doi/10.1073/pnas.2321545121
1335 OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition
https://www.pnas.org/doi/10.1073/pnas.2315348121
1334 Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression
https://www.pnas.org/doi/10.1073/pnas.2317760121
1333 Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc
https://www.pnas.org/doi/10.1073/pnas.2404188121
1332 A blueprint for tumor-infiltrating B cells across human cancers
https://www.science.org/doi/10.1126/science.adj4857
1331 Deficiency of factor-inhibiting HIF creates a tumor-promoting immune microenvironment
https://www.pnas.org/doi/10.1073/pnas.2309957121
|
